TScan Therapeutics, Inc. Common Stock(TCRX)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

TCRX iron condor setups TCRX expected move TCRX IV rank history TCRX Fibonacci levels

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

TCRX — —
Snapshot
Info
Industry (SIC)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) (2836)
Exchange
XNAS
Market Cap
$0.1B

TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
MonthAvg ReturnYears of Data
Jan +0.41% 5
Feb +14.01% 5
Mar -13.85% 5
Apr +8.14% 5
May +14.10% 5
Jun -6.34% 5
Jul +3.95% 6
Aug -7.88% 5
Sep -3.73% 5
Oct +7.38% 5
Nov +1.42% 5
Dec -22.17% 5
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $0.97
SMA 50: $0.97
SMA 200: $1.15
Current: $0.77
EMA 12: $0.89
EMA 26: $0.94
MACD: -0.0466 | Signal: -0.0239
BEARISH
ADX (14): 17.83
RANGE
+DI: 14.97
−DI: 22.64
Momentum Oscillators
RSI (14): 34.97
NEUTRAL
Stoch %K: 0.76
Stoch %D: 3.41
Williams %R: -98.44
Volume & Volatility
BB Upper: $1.20
BB Lower: $0.75
NEUTRAL
OBV: -14,487,759
Vol SMA 20: 936,330
Vol ROC: -21.58%
ATR: $0.09
True Range: $0.11
HV 20: 107.6%
HV 30: 110.3%
HV 60: 87.7%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-07-29T00:00:00 – 2026-07-27T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
Options Activity
Loading options activity...
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
1.82
Correlation (SPY)
26.4%
R²
0.07
Ann. Volatility
87.6%
SPY Volatility
12.7%

High volatility - stock moves more than market

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-06-30

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

60 filers32,560,123 shares$32.29M value
# Filer Shares Value % of Total % of Float Period
1 Lynx1 Capital Management LP 8,019,148 $8.10M 25.08% — 2026-03-31
2 BVF INC/IL 5,564,290 $5.62M 17.40% — 2026-03-31
3 BAKER BROS. ADVISORS LP 2,784,792 $2.81M 8.71% — 2026-03-31
4 VANGUARD GROUP INC Custodian 2,475,733 $2.48M 7.67% — 2025-12-31
5 BlackRock, Inc. Custodian 1,840,952 $1.86M 5.76% — 2026-03-31
6 MILLENNIUM MANAGEMENT LLC Custodian 1,460,285 $1.47M 4.57% — 2026-03-31
7 RENAISSANCE TECHNOLOGIES LLC 1,364,783 $1.38M 4.27% — 2026-03-31
8 Deer Management Co. LLC 1,245,504 $1.26M 3.90% — 2026-03-31
9 TWO SIGMA INVESTMENTS, LP 1,209,009 $1.22M 3.78% — 2026-03-31
10 Aberdeen Group plc 918,020 $927.20K 2.87% — 2026-03-31
11 JACOBS LEVY EQUITY MANAGEMENT, INC 808,356 $816.44K 2.53% — 2026-03-31
12 DC Funds, LP 630,000 $630.00K 1.95% — 2026-03-31
13 GEODE CAPITAL MANAGEMENT, LLC Custodian 616,952 $623.34K 1.93% — 2026-03-31
14 D. E. Shaw & Co., Inc. Custodian 319,587 $322.78K 1.00% — 2026-03-31
15 CITADEL ADVISORS LLC Custodian 318,411 $321.60K 1.00% — 2026-03-31
16 MARSHALL WACE, LLP Custodian 237,346 $239.72K 0.74% — 2026-03-31
17 MORGAN STANLEY Custodian 225,829 $225.83K 0.70% — 2025-12-31
18 STATE STREET CORP 207,313 $209.39K 0.65% — 2026-03-31
19 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian 157,228 $158.80K 0.49% — 2026-03-31
20 JANE STREET GROUP, LLC Custodian 144,421 $145.87K 0.45% — 2026-03-31
21 BROWN BROTHERS HARRIMAN & CO 143,051 $144.48K 0.45% — 2026-03-31
22 Verdad Advisers, LP 134,001 $135.34K 0.42% — 2026-03-31
23 BRIDGEWAY CAPITAL MANAGEMENT, LLC 111,900 $113.02K 0.35% — 2026-03-31
24 NORTHERN TRUST CORP Custodian 97,448 $98.42K 0.30% — 2026-03-31
25 LETKO, BROSSEAU & ASSOCIATES INC 95,875 $96.83K 0.30% — 2026-03-31
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period
Insider Activity
Latest: 2026-05-22
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-05-22 Katina Dorton Director Grant (A) +67,000 opt — EDGAR
2026-05-22 Garry A Nicholson Director Grant (A) +67,000 opt — EDGAR
2026-05-22 Gabriela Gruia Director Grant (A) +67,000 opt — EDGAR
2026-05-22 Barbara Klencke Director Grant (A) +67,000 opt — EDGAR
2026-05-22 Keith Woods Director Grant (A) +67,000 opt — EDGAR
2026-05-22 667, L.P. Director Grant (A) +804,000 opt — EDGAR
2026-01-22 Gavin MacBeath Chief Executive Officer Grant (A) +1,165,000 opt — EDGAR
2026-01-22 Chrystal Louis Chief Medical Officer Grant (A) +420,000 opt — EDGAR
2026-01-22 Jason Amello Chief Financial Officer Grant (A) +350,000 opt — EDGAR
2026-01-22 ZORAN ZDRAVESKI See Remarks Grant (A) +350,000 opt — EDGAR
2026-01-22 Leiden Dworak See Remarks Grant (A) +100,000 opt — EDGAR
2025-12-23 Weston Nichols 10%+ Owner Buy (P) +323,602 $0.90 $291.1K EDGAR
2025-07-02 Gabriela Gruia Director Grant (A) +67,000 opt — EDGAR
2025-07-02 Katina Dorton Director Grant (A) +67,000 opt — EDGAR
2025-07-02 667, L.P. Director Grant (A) +804,000 opt — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
12 insiders · @ $0.77
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Weston Nichols 10%+ Owner 8,019,148 $6.16M $163.1K 2 2025-12-23
2 Lynx1 Capital Management LP 10%+ Owner 6,746,141 $5.18M $6.99M 5 2025-05-21
3 Christoph H Westphal 10%+ Owner 1,036,585 $796.4K $2.00M 1 2021-07-22
4 Baker Bros. Advisors (GP) LLC Director 253,327 $194.6K $15.35M 1 2022-05-12
5 DAVID P SOUTHWELL Chief Executive Officer 171,569 $131.8K $185.9K 6 2023-02-06
6 Baker Brothers Life Sciences LP Director 104,698 $80.4K $128.25M 3 2024-04-23
7 TIMOTHY J BARBERICH Director 99,969 $76.8K $242.0K 5 2023-12-21
8 Barbara Klencke Director 70,000 $53.8K $108.0K 8 2026-05-22
9 Gavin MacBeath Chief Executive Officer 49,710 $38.2K $31.1K 7 2026-01-22
10 Brian M. Silver Chief Financial Officer 29,727 $22.8K $156.7K 9 2023-06-15
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
Notice of Proposed Sale (Form 144)
Latest: 2024-08-23
Last 30d: 0 filings  ·  Last 90d: 0 filings

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. Amendments (Form 144/A) and post-cancellation refilings can inflate this if you sum naively; the rollup above excludes filings with zero stated value.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2024-08-23 ZDRAVESKI ZORAN Officer 164,686 $905.8K 2024-08-23 Morgan Stanley Smith Barney LLC … — EDGAR
2023-05-15 SOUTHWELL DAVID P Director 85,911 $346.2K 2023-05-15 Charles Schwab Company — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.